Home / Compare / Tesamorelin vs sermorelin

Tesamorelin vs sermorelin

Same mechanism, very different standing: one is an approved drug with a label dose, the other has no product on the market.

Short answer: both make the pituitary release more growth hormone. Tesamorelin (Egrifta WR) is FDA-approved for abdominal fat in adults with HIV, at 1.28 mg once daily. Sermorelin has had no approved product since 2009, so there is no FDA-reviewed dose. They have never been tested against each other.
TesamorelinSermorelin
What it isModified full-length GHRH (44 amino acids)First 29 amino acids of GHRH (GRF 1-29)
How it worksMakes the pituitary release growth hormone, raising IGF-1Same mechanism
US statusFDA-approved (Egrifta, since 2010; Egrifta WR since 2025)No marketed product. Geref was withdrawn in 2009
Approved useReducing excess abdominal fat in adults with HIV and lipodystrophyNone today (Geref was for children with GH deficiency)
Label doseEgrifta WR: 1.28 mg under the skin once dailyNo current label, so no approved dose
Mixing11.6 mg vial + 1.3 mL bacteriostatic water; vial lasts 7 daysNo label instructions
Where it comes fromPharmacy, on prescriptionCompounding pharmacies or unregulated sellers

What this means in practice

Tesamorelin's dose, mixing and 7-day discard rule all come from its label, and the trials behind it were in a specific group: adults with HIV and lipodystrophy. Using it for anti-aging or general fat loss is off-label. Sermorelin sold today is compounded or unregulated, so its strength and purity depend on the source, and there is no current label to set a dose.

More detail: tesamorelin · sermorelin ·sermorelin units calculator

Questions

Is tesamorelin better than sermorelin?
They have not been compared head to head. The practical difference is evidence and regulation: tesamorelin is an FDA-approved product with trial data and a set dose for one specific use, while sermorelin has no marketed product and no FDA-reviewed adult dose.
Are tesamorelin and sermorelin the same thing?
No. Both are versions of growth-hormone-releasing hormone (GHRH), but sermorelin is only the first 29 amino acids, while tesamorelin is the full 44-amino-acid hormone with a chemical change that makes it last longer.
Is sermorelin FDA-approved?
Not today. The brand Geref was approved in 1997 and withdrawn in 2009. In 2013 the FDA said the withdrawal was not for safety or effectiveness reasons, but compounded sermorelin does not carry that old approval.
What is the tesamorelin dose?
For Egrifta WR the label dose is 1.28 mg under the skin once daily, for HIV-associated abdominal fat. The older Egrifta SV was 1.4 mg daily. There is no approved dose for anti-aging or general fat loss.

Sources

  1. FDA label: Egrifta WR (tesamorelin) 2025
  2. DailyMed: Egrifta (tesamorelin) labeling
  3. Federal Register 2013: Determination that Geref (sermorelin) was not withdrawn for safety or effectiveness
  4. FDA: 503A bulk drug substance categories (updated May 14, 2026, PDF)

Last checked 2026-11-16. How we pick and check sources: methodology.